GLRX: A Potential Drug Target for Cellular Growth, Stress Response and DNA Replication

Target Name: GLRX

NCBI ID: G2745

GLRX

GLRX: A Potential Drug Target for Cellular Growth, Stress Response and DNA Replication

GLRX (Thioltransferase-1) is a protein that is expressed in a variety of tissues throughout the body, including the liver, heart, and kidneys. It is a member of the thiol transferase family of proteins, which are involved in the transfer of thiols , also known as redox electrons, from one molecule to another.

Thiols are important molecules that play a variety of roles in cellular metabolism and signaling. They can act as antioxidants, reducing the oxidative stress that can damage cellular components and contribute to a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. can also act as signaling molecules, participating in a variety of signaling pathways that regulate cellular processes such as cell growth, differentiation, and inflammation.

Thiol transferase enzymes are involved in the transfer of thiols from one molecule to another. This process involves a series of steps, including the formation of a thiol-transferase complex, the transfer of the thiol from the donor molecule to the acceptor molecule, and the formation of a disulfide bond. Thiol transferase enzymes are involved in a wide range of biological processes, including the regulation of cellular signaling pathways, DNA replication, and cellular stress response.

GLRX is a thiol transferase enzyme that is expressed in a variety of tissues throughout the body. It is expressed in the liver, heart, and kidneys, and has been shown to be involved in the regulation of cellular signaling pathways, including the signaling pathway that regulates cell growth and differentiation.

GLRX has been shown to play a role in the regulation of cell growth and differentiation. It has been shown to be involved in the inhibition of cell proliferation, and to promote the regulation of cellular processes that are important for cell differentiation and tissue regeneration. This is important because many diseases, including cancer, are characterized by uncontrolled cell growth and proliferation. By promoting the regulation of cell growth and differentiation, GLRX may be a potential drug target or biomarker for the treatment of these diseases.

GLRX has also been shown to be involved in the regulation of cellular stress response. It has been shown to be involved in the regulation of cellular stress responses, including the stress response that occurs in response to environmental toxins or other stressors. This is important because Many diseases, including neurodegenerative diseases, are characterized by cellular stress responses that contribute to their development and progression. By regulating cellular stress responses, GLRX may be a potential drug target or biomarker for the treatment of these diseases.

GLRX has been shown to play a role in the regulation of DNA replication. It has been shown to be involved in the regulation of DNA replication, including the proofreading of DNA replication errors and the repair of damaged DNA. This is important because many diseases, including cancer, are characterized by DNA replication errors that contribute to their development and progression. By regulating DNA replication, GLRX may be a potential drug target or biomarker for the treatment of these diseases.

In conclusion, GLRX is a thiol transferase enzyme that is expressed in a variety of tissues throughout the body. It is involved in the regulation of cellular signaling pathways, cell growth and differentiation, stress response, and DNA replication. As a potential drug target or biomarker, GLRX may be a useful agent for the treatment of diseases characterized by uncontrolled cell growth and proliferation, cellular stress responses, or DNA replication errors. Further research is needed to fully understand the role of GLRX in these diseases and to develop effective treatments.

Protein Name: Glutaredoxin

Functions: Has a glutathione-disulfide oxidoreductase activity in the presence of NADPH and glutathione reductase. Reduces low molecular weight disulfides and proteins

The "GLRX Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GLRX comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets